Thousands of men in England living with advanced prostate cancer are poised to benefit from a new life-extending drug, ...

Abiraterone will be available in a matter of weeks and will be offered to 7,000 men a year.

Thousands of men with incurable prostate cancer will be offered a lifeline after an about-turn on NHS treatment.

The U.S. Food and Drug Administration (FDA) has granted fast track designation to Alessa Therapeutics for its lead product ...

Thousands of men with prostate cancer will be offered a life-extending drug on the NHS within weeks. For the first time patients whose prostate cancer has not spread will be able to receive the drug ...

In a statement, NICE said the new guidance for Talzenna will make it an option for around 2,400 people in England and reduce ...

The known prostate cancer drug, Abiraterone, will be accessible for patients in the coming week, after a campaign led by a ...

Data from a major U.S. clinical trial from the Alliance for Clinical Trials in Oncology has uncovered a genetic factor that ...

Dr. William Russell specializes in radiation oncology in Baton Rouge. He graduated from the University of Mississippi School of Medicine in 1984. Russell is double-board certified in internal medicine ...

The decision means Northern Ireland remains the only country in the UK where patients with this stage of prostate cancer are ...

A major study of nearly 19,000 men has found that a baldness drug significantly cut the risk of prostate cancer, but its side effects may keep many from using it to prevent what has become the second ...

Many commonly prescribed drugs have surprising other uses. Sept. 28, 2010 -- Viagra is well recognized for its primary use. But who knew it would show promise as a cancer fighter, too? Medical ...